Steroid Use in Non-RSV Bronchiolitis

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
The proposed study is a pilot randomized control trial to determine the efficacy of dexamethasone use in hospitalized children who are less than 2 years of age with non-respiratory syncytial virus (RSV) bronchiolitis admitted to the University of Pittsburgh Medical Center (UPMC) Children\'s Hospital of Pittsburgh from February 1 to May 31, 2022. It is hypothesized that the use of standard airway-dose steroids (0.6mg/kg dexamethasone) will improve the clinical outcome of children hospitalized for non-RSV bronchiolitis, which will be evident by decreased length of stay.
Epistemonikos ID: 3ac506e5547a071b86f1035e09fc7c4a765b3e36
First added on: Mar 23, 2020